retatrutide clinical trials obesity ⭐️topline results from TRIUMPH-1, a Phase 3 trial evaluating #retatrutide, an investigational GIP / GLP-1 / glucagon triple hormone receptor agonist, in adults with or “overweight” retatrutide clinical trials weight loss

Many studies do not fully control for dietary intake, physical activity, or concurrent lifestyle changes all of which independently affect weight and cardiometabolic risk

Demonstrating the additive or synergistic efficacy and safety of components in combination therapies is more complicated than the evaluation of monotherapies and may require the use of factorial study designs that employ larger sample sizes, which results in increased costs

GLP-1, Parkinson's Disease, and Neuroprotection

Strategies for preventing anterior cruciate ligament injuries in athletes: insights from a scoping review

These hormones are released in response to food intake, particularly carbohydrates and fats

J Clin Invest 127(3):10311045 Llewellyn-Smith IJ et al (2011) Preproglucagon neurons project widely to autonomic control areas in the mouse brain